Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Legally Induced Abortion Without Mention of Complication Clinical Trial

Official title:
Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Status Withdrawn

Clinical Trial Summary

Dilation and evacuation (D&E) is a common surgical procedure in the U.S. Adequate pre-operative preparation of the uterine cervix is an important part of preventing complications of the procedure. Traditionally, the uterine cervix is prepared for the procedure using water-attracting dilators, which are placed via a speculum exam and cause discomfort for many women. The objective of this study is to investigate the comparative effectiveness of mifepristone (an oral tablet) versus dilators for cervical preparation for D&E.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Legally Induced Abortion Without Mention of Complication

Clinical Trial Details

NCT number	NCT02679092
Study type	Interventional
Source	Stanford University
Contact
Status	Withdrawn
Phase	N/A
Start date	April 2016
Completion date	December 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02191774` - Medical Abortion up to 10 Weeks Gestation at Home
Recruiting	`NCT02708446` - A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion	Phase 4
Completed	`NCT01862991` - Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services	N/A